Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-04-15 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2020年年度审计报告
Annual Report Classification · 100% confidence The document is titled as "财务报表及审计报告 2020 年 12 月 31 日止年度" which translates to "Financial Statements and Audit Report for the year ended December 31, 2020." It contains detailed financial statements including consolidated and company balance sheets, income statements, cash flow statements, and shareholders' equity changes. It also includes a comprehensive audit report by registered auditors, detailing audit opinions, key audit matters, management responsibilities, and auditor responsibilities. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. The presence of detailed financial data and the audit report confirms this is a full annual financial report with audit information, not just an audit report alone or an announcement. Therefore, the document fits the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. FY 2020
2021-04-15 Chinese
申万宏源证券承销保荐有限责任公司关于康泰医学系统（秦皇岛）股份有限公司2020年内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed internal control self-evaluation report for the year 2020 of 康泰医学系统（秦皇岛）股份有限公司, verified by the sponsoring institution 申万宏源证券承销保荐有限责任公司. It includes extensive descriptions of internal control systems, evaluation scope, defect recognition standards, and conclusions on internal control effectiveness. The document is not a full annual report or audit report but specifically focuses on internal control evaluation and the sponsoring institution's verification opinion. It is not a brief announcement or certification but a substantive report on internal control. This matches the definition of an Audit Report / Information (AR), which includes audit reports, applied accounting principles, and internal control evaluations, excluding full annual reports. The document length (6902 characters) and content confirm it is a standalone internal control audit report rather than an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2020
2021-04-15 Chinese
监事会关于公司内部控制自我评价报告的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's opinion on the company's internal control self-evaluation report for the year 2020. It references the internal control self-evaluation report but does not contain the full report or detailed financial data. The document is short (461 characters) and serves as an official announcement or opinion rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS), which is a fallback category for such announcements and opinions that do not contain full reports or detailed financial data.
2021-04-15 Chinese
关于公司董事辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of two company directors, including details about the impact on the board composition and related corporate governance matters. It does not contain financial data, audit information, or report content. It specifically concerns changes in the company's board of directors. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification.
2021-04-15 Chinese
2020年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2020 年年度报告摘要" which translates to "2020 Annual Report Summary". It contains detailed financial data for the year 2020, including revenue, net profit, earnings per share, and other key financial metrics. It also includes management discussion and analysis of business operations, R&D, marketing, production, and other aspects. The document references the auditor's opinion (Deloitte) and discusses accounting policy changes, which are typical components of an annual report. The length of the document (6918 characters) and the detailed financial and operational data indicate this is the report itself, not just an announcement or summary notice. Therefore, the document fits the definition of an Annual Report (10-K). FY 2020
2021-04-15 Chinese
申万宏源证券承销保荐有限责任公司关于康泰医学系统（秦皇岛）股份有限公司2020年度募集资金存放与使用情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from the sponsor (申万宏源证券承销保荐有限责任公司) regarding the 2020 annual special audit of the raised funds' deposit and usage by 康泰医学系统（秦皇岛）股份有限公司. It includes specifics on the amount raised, usage, changes in investment projects, compliance with regulatory requirements, and audit opinions by Deloitte. The document references regulatory guidelines on raised funds management and includes a signed audit opinion. This is a specialized audit report focused on the use and management of funds raised in the IPO, not a full annual report or earnings release. It is not a mere announcement or certification but contains substantive audit findings and detailed financial data related to the raised funds. Therefore, it fits the category of an Audit Report / Information (AR). FY 2020
2021-04-15 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.